819 related articles for article (PubMed ID: 26701853)
21. Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.
Li A; Yan Q; Zhao X; Zhong J; Yang H; Feng Z; Du Y; Wang Y; Wang Z; Wang H; Zhou Y; Liu S; Nie Y
Oncotarget; 2016 Jan; 7(1):524-37. PubMed ID: 26594798
[TBL] [Abstract][Full Text] [Related]
22. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
23. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
25. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer.
Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ
Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638
[TBL] [Abstract][Full Text] [Related]
26. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
Liu T; Chen J; Xiao S; Lei X
Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
[TBL] [Abstract][Full Text] [Related]
27. Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.
Shi Z; Liu J; Yu X; Huang J; Shen S; Zhang Y; Han R; Ge N; Yang Y
Ann Surg Oncol; 2016 Jan; 23(1):211-7. PubMed ID: 25824262
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.
He N; Park K; Zhang Y; Huang J; Lu S; Wang L
Gastroenterology; 2008 Mar; 134(3):793-802. PubMed ID: 18325392
[TBL] [Abstract][Full Text] [Related]
30. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
31. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
32. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
[TBL] [Abstract][Full Text] [Related]
33. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
[TBL] [Abstract][Full Text] [Related]
35. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
36. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
37. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
38. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
39. Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.
Liu J; Zhang C; Lin M; Zhu W; Liang Y; Hong X; Zhao Y; Young KH; Hu W; Feng Z
Oncotarget; 2014 May; 5(9):2635-47. PubMed ID: 24797434
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
